9063

GDT Ontario Health Testing Eligibility HCT v3 GTD Indications Diagnosis Carrier / Cascade Testing GTD Samples Accepted Blood DNA DNA (Not Accepted for MLPA) GTD Test Methodology CNV Sequencing GTD Methodology Notes NGS + Targeted Array; MLPA GTD Notes DNA not accepted for MLPA Generic Test name (cms title) Neurofibromatosis type 1 GTD Test type Gene Panel GTD Location The Hospital for Sick Children GTD Gene/Platform/Region List NF1, SPRED1 GTD Category Cancer GTD Disease/Condition Neurofibromatosis Type 1(NF1), Von Recklinghausen Disease, Legius Syndrome